Cheung et al. reported that higher FSHR and LHCGR expression is associated with early stage, low grade ovarian cancer and the expression is reduced in HGSOC compared to benign ovarian tumors (Cheung et al., 2020). Here, FSHR is linked to ovarian cancer.